Disclaimer

Rights Issue - Important Information

Electronic versions of the materials you are seeking to access are being made available on this webpage in good faith and for information purposes only. These materials are not directed at or accessible by persons domiciled in the United States, Canada, Japan or Australia, or in any other country where participation in the issue would require additional prospectuses, registration or other measures other than those pursuant to Swedish law or would conflict with regulations in such country. Please read this notice carefully - it applies to all persons who view this webpage. Please note that the information set out below may be altered or updated. You should read this message in full each time you visit the site.

Foreign Persons

Viewing the materials you seek to access may not be lawful in certain jurisdictions. In other jurisdictions, only certain categories of person may be allowed to view such materials. Any persons who wish to view these materials must first satisfy themselves that they are not subject to any local requirements that prohibit or restrict them from doing so.

The materials on this webpage are not for distribution or transmission, directly or indirectly, in or into the United States, Canada, Japan or Australia. The rights offering is not directed to shareholders or other investors domiciled in the United States, Canada, Japan or Australia, or in any other country where participation in the issue would require additional prospectuses, registration or other measures other than those pursuant to Swedish law or would conflict with regulations in such country. No shares, interim shares, subscription rights or other securities issued by Orexo AB (publ) (“Orexo”) have been or will be registered in accordance with the United States Securities Act of 1933, or in accordance with any securities legislation in any state of the United States or any province in Canada. Accordingly, no new shares, interim shares, subscription rights or other securities issued by Orexo may be transferred or offered for sale in the United States or Canada, other than in such exceptional cases that do not require registration. The rights offering is directed only at (i) persons who are outside the United Kingdom; or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended); or (iii) persons to whom it can otherwise lawfully be directed at.

If you are not permitted to view materials on this webpage or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.

I have read, understood and accept the above and declare that I am not domiciled in the United States, Canada, Japan or Australia:

Yes, I accept.No, I do not accept.